Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles

被引:252
作者
Bilati, U [1 ]
Allémann, E [1 ]
Doelker, E [1 ]
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva, Switzerland
关键词
biodegradable polymers; nanoparticles; microparticles; peptides; PLGA; PLA; proteins; stabilization;
D O I
10.1016/j.ejpb.2004.10.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper reviews the major factors that are closely involved in peptide and protein degradation during the preparation of biodegradable nano- and microparticles. The various means usually employed for overcoming these obstacles are described, in order to bring to the fore the strategies for protein stabilization. Both processing and formulation parameters can be modified and are distinctly considered from a strategic point of view. We describe how partial or full protein stability retention within the carriers and during drug release might be achieved by individual or combined optimized strategies. Additionally, problems commonly encountered during protein quantification, stability determination and release are briefly reviewed. Artefacts that might occur during sampling and analytical procedures and which might hinder critical interpretation of results are discussed. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:375 / 388
页数:14
相关论文
共 122 条
[1]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[2]   Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents [J].
Audran, R ;
Men, Y ;
Johansen, P ;
Gander, B ;
Corradin, G .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1111-1116
[3]   Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (01) :1-9
[4]   Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics [J].
Bittner, B ;
Morlock, M ;
Koll, H ;
Winter, G ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :295-305
[5]   Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants [J].
Blanco, D ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (03) :285-294
[6]   Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[7]  
BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149
[8]   ADSORPTION OF SALMON-CALCITONIN TO PLGA MICROSPHERES [J].
CALIS, S ;
JEYANTHI, R ;
TSAI, T ;
MEHTA, RC ;
DELUCA, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :1072-1076
[9]   Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein [J].
Carrasquillo, KG ;
Stanley, AM ;
Aponte-Carro, JC ;
De Jésus, P ;
Costantino, HR ;
Bosques, CJ ;
Griebenow, K .
JOURNAL OF CONTROLLED RELEASE, 2001, 76 (03) :199-208
[10]   Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation [J].
Carrasquillo, KG ;
Carro, JCA ;
Alejandro, A ;
Toro, DD ;
Griebenow, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (01) :115-120